Skip to main content
. 2015 Jan 13;112(4):1007–1012. doi: 10.1073/pnas.1409403112

Fig. 3.

Fig. 3.

Comparison of cancer therapies. For the parameter setting of Fig. 2D, different therapies are compared via 1,000 forward simulations with K=104. Shown is the fraction of runs that have not yet developed a metastasis mutation as a function of elapsed time. All-out maximum dosage therapy (u1) is only slightly better than no therapy (u0) in avoiding metastasis. Much better is metronome therapy with τon=τoff=0.1Kgenerations, with almost 70% success rate (values numerically optimized). Adaptive therapy removes the tumor in close to 90% of runs.